Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Improving Translational Accuracy02:07

Improving Translational Accuracy

8.5K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
8.5K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

150
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
150
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

278
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
278
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

37
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
37
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

477
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
477
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

211
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
211

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Immunological Biomarkers for Personalized Treatment Selection in Severe COVID-19: Post Hoc Machine Learning Analysis of a Randomized Clinical Trial.

JMIR medical informatics·2026
Same author

ChatGPT-4.0 and Medical Students: A Recognition-Gated Comparative Evaluation on Image-Based Medical Examinations.

Journal of medical education and curricular development·2026
Same author

Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AML.

Antimicrobial agents and chemotherapy·2026
Same author

Mpox in Children and Adolescents.

The Pediatric infectious disease journal·2026
Same author

Rising Antifungal Resistance in Candidozyma auris: Signals, Gaps, and the Path Forward.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Global Review on <i>Naegleria fowleri</i> Cases: Contemporary Epidemiology, Diagnosis, Treatment and Outcomes.

Infectious disease reports·2026

Related Experiment Video

Updated: May 23, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.6K

Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project.

Salma Malik1, Zoi Pana Dorothea2, Christos D Argyropoulos3

  • 1European Clinical Research Infrastructure Network, Paris, France.

JMIR Medical Informatics
|March 8, 2025
PubMed
Summary
This summary is machine-generated.

Master protocols enhance clinical trial efficiency and data interoperability. Adopting shared data standards and infrastructure is crucial for seamless data interpretation and analysis across studies.

Keywords:
adultclinical trialsdata managementharmonizationinteroperabilitymetadatapediatricprotocolstandardssystems

More Related Videos

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

2.8K
Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

10.1K

Related Experiment Videos

Last Updated: May 23, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.6K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

2.8K
Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

10.1K

Area of Science:

  • Clinical research
  • Data science
  • Vaccinology

Background:

  • Data standards are essential for efficient data processing and interoperability in clinical trials.
  • Structured data facilitates analysis, reduces cleaning efforts, and enables secondary data use.
  • A common language and shared expectations improve system and device interoperability.

Purpose of the Study:

  • Identify commonalities and differences in clinical trial metadata, protocols, and data collection within the VACCELERATE project.
  • Assess the achieved interoperability and suggest methodological improvements.
  • Evaluate the impact of data standards on clinical trial processes.

Main Methods:

  • Interoperable points were identified based on core outcome areas: immunogenicity, safety, and efficacy.
  • Compared 3 VACCELERATE clinical trial protocols against a master protocol template.
  • Analyzed metadata and conducted a questionnaire survey on data management systems and structures.

Main Results:

  • Noncommonalities in protocols and metadata were linked to population differences, protocol design, and vaccination patterns.
  • Detailed metadata followed internal standards and the Clinical Data Acquisition Standards Harmonisation (CDASH) approach.
  • A single data management provider streamlined database development, ensuring uniformity and secure data transfer.

Conclusions:

  • Master protocols significantly improve trial operational efficiency and data interoperability when uniform infrastructure and data management are used.
  • Shared data must be structured, described, formatted, and stored using recognized standards for better interpretation and analysis.
  • Adherence to widely recognized data and metadata standards is key to enhancing data interoperability and facilitating research.